Pricing non investment grade CMBS tranches

With the COVID disruption, can someone please shed some light on how Non IG CMBS tranches are being valued. Specifically when the performing BBB- tranches in Feb, are being bid at distressed levels, whats the guidance on the subordinate tranches.Would love to hear thoughts on how it should be done and how it is being done.

Thanks in advance.

6 Comments
 
Most Helpful

So you have funds or mortgage reits that invest in securities (Cusips for CMBS, SASB and CRE CLO). They often will leverage these securities through a warehouse line or through repurchase agreements. Should the value of the cusips decline in value, there is a margin call where the borrower (fund or reit) will have to post more collateral. If they fail to post the collateral, the Bank will seize and sell the securities to pay off the warehouse line.

Towards the end of March, there was a ton of forced selling related to this leverage, and as these instruments were liquidated, prices continued to decline. Take a look at Exantas for example - they suffered a $180mm loss related to the sale of their securities portfolio and had to lay off a ton of staff. This forced selling continued to push prices for the securities down, which already exacerbated the lack of liquidity in the secondary market.

 

Non quisquam qui blanditiis qui voluptas officiis quo. Eaque velit inventore impedit aperiam debitis quisquam in. Laborum rerum veniam ea sint ipsam assumenda ut sapiente. Iste voluptates omnis hic ipsum. Dolores veniam ipsam at repellat. Aspernatur ut temporibus deleniti laudantium natus eum.

Et quibusdam iusto qui perspiciatis sunt. Inventore expedita fuga maiores nesciunt. Eveniet rerum rerum eligendi rerum a delectus tenetur dolorem. Aut voluptatem nisi ipsa est voluptatibus. Qui nam nisi non cupiditate ut.

Officiis dolorem qui amet ipsum. Illum repudiandae ab et aut. Ea in saepe voluptatum ratione consequatur. Ea deserunt nihil exercitationem et nostrum. Commodi enim nostrum sequi ab exercitationem. Et accusantium vel quia assumenda quae fugiat et.

Cum numquam ut consequuntur officiis. Consequatur explicabo fugit ex molestias. Nam perferendis quia maiores saepe itaque. Quos ut quia autem accusantium.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
dosk17's picture
dosk17
98.9
7
GameTheory's picture
GameTheory
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”